The Effervescent Products market is on the brink of significant expansion between 2024- 2031. In 2024, the market is valued at US $ 43 billion and is expected to reach US $ 68 billion by 2031.
This product will be delivered within 1-3 business days.
Driving Factors:
- Increase in the Prevalence of Chronic Diseases: The rising incidence of chronic diseases like Dysphagia, Esophageal Cancer, and others that hinder swallowing is a major driver of market growth. Effervescent dosage forms offer a convenient solution, as they transform into a solution with a drop of water, enabling easy swallowing and faster absorption compared to standard tablets.
- Increased Health Consciousness: Growing health awareness and higher disposable incomes have prompted consumers to opt for healthy products such as dietary supplements, probiotics, vitamins, and minerals. Market players are capitalizing on this trend by offering effervescent products that cater to disease prevention, nutritional deficiencies, and overall health improvement.
- Increasing Investment in Healthcare Infrastructure: The growth of the Effervescent Products Market is facilitated by the escalating healthcare expenditure aimed at enhancing healthcare infrastructure. Governments worldwide are strengthening their healthcare systems by allocating increased budgets, driving the demand for Effervescent Products to treat chronic diseases.
- Extensive Research and Development Initiatives: The rising number of research and development activities is propelling market growth. Pharmaceutical companies are focusing on developing innovative medications with tangible benefits for patients' health and lifestyle. The development of effervescent products that transform into beverages not only benefits the environment by reducing plastic usage but also aids patients in swallowing medication easily. Substantial investments in innovative technologies and novel effervescent products are expected to create favorable opportunities for market expansion.
Challenges Ahead:
- High Cost Associated with Drug Development: The substantial financial resources required for drug development and research activities could impede the growth rate of the Effervescent Products Market. Additionally, the lack of healthcare infrastructure and limited availability of effervescent products in underdeveloped countries may act as restraints, limiting market growth.
- High Sodium Content in Effervescent Products: Effervescent products contain sodium bicarbonate, which induces fizzing and dissolution. However, sodium bicarbonate has been associated with health issues, including high blood pressure, increasing the risk of cardiovascular disorders. The high sodium content in effervescent products could negatively impact market growth.
Competitive Landscape:
The Effervescent Products Market is fiercely competitive, with several major players vying for dominance. Key companies are focusing on the development and introduction of user-friendly dosage forms such as effervescent tablets, powders, and granules to expand their product portfolios, boost revenue, and prolong product lifespans.Key Companies Profiled:
- Reckitt Benckiser Group Plc
- GlaxoSmithKline Plc.
- Bayer AG
- Nuun and Company Inc.
- Bristol-Myers Squibb Co (UPSA Laboratories)
- Herbalife International of America, Inc.
- Prestige Brands, Inc.
- DMK Group (Sanotact GmbH)
- Hermes Arzneimittel GmbH
- Pyramid Pharmaceuticals
- Amerilab Technologies Inc.
- US Pharma Lab Incorporated
- Tower Laboratories, Ltd
- Laboratoires SMB
- Paragon Labs USA
- Marlyn Nutraceuticals, Inc.
- JW Nutritional, LLC
- Nomax Inc.
- Nutrilo GmbH
Effervescent Products Market Categorization
Effervescent Products Market by Product Form
- Effervescent Tablets
- Effervescent Powders
- Effervescent Granules
Effervescent Products Market by Product Type
- Pharmaceuticals
- Functional Foods
- Probiotics
- Dietary Supplements
- Electrolytes & Energy Boosting Supplements
- Dental Products
- Dental Cleaners
- Teeth Whitening
Effervescent Products Market by Sales Channel
- Pharmacies
- Drug Stores
- E-Commerce
- Hypermarkets & Supermarkets
- Multi-Level Marketing Channels
Effervescent Products Market by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Effervescent Products Market Outlook, 2018 - 2031
4. North America Effervescent Products Market Outlook, 2018 - 2031
5. Europe Effervescent Products Market Outlook, 2018 - 2031
6. Asia Pacific Effervescent Products Market Outlook, 2018 - 2031
7. Latin America Effervescent Products Market Outlook, 2018 - 2031
8. Middle East & Africa Effervescent Products Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned
- Reckitt Benckiser Group Plc
- GlaxoSmithKline Plc.
- Bayer AG
- Nuun and Company Inc.
- Bristol-Myers Squibb Co (UPSA Laboratories)
- Herbalife International of America, Inc.
- Prestige Brands, Inc.
- DMK Group (Sanotact GmbH)
- Hermes Arzneimittel GmbH
- Pyramid Pharmaceuticals
- Amerilab Technologies Inc.
- US Pharma Lab Incorporated
- Tower Laboratories, Ltd
- Laboratoires SMB
- Paragon Labs USA
- Marlyn Nutraceuticals, Inc.
- JW Nutritional, LLC
- Nomax Inc.
- Nutrilo GmbH
Methodology
LOADING...